Skip to main content

Vericel Corp

For the period ended Mar 31, 2024. Filed May 8, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed May 8, 2024

VCEL$58.39+6.9%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Operations

(Unaudited, amounts in thousands, except per share amounts)

Three Months Ended March 31,
20242023
Product sales, net$51,281$41,017
Total revenue51,28141,017
Cost of product sales15,92714,497
Gross profit35,35426,520
Research and development6,4185,212
Selling, general and administrative34,40029,485
Total operating expenses40,81834,697
Loss from operations(5,464)(8,177)
Other income (expense):
Interest income1,762839
Interest expense(153)(145)
Other expense(7)(12)
Total other income1,602682
Net loss$(3,862)$(7,495)
Net loss per common share:
Basic and diluted$(0.08)$(0.16)
Weighted-average common shares outstanding:
Basic and diluted48,14147,387
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.